Analysis of Cost Minimization of Adalimumab Compared With Infliximab for The Treatment of Ulcerative Colitis In The Public Market In Mexico
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.526
https://www.valueinhealthjournal.com/article/S1098-3015(15)02602-9/fulltext
Title :
Analysis of Cost Minimization of Adalimumab Compared With Infliximab for The Treatment of Ulcerative Colitis In The Public Market In Mexico
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)02602-9&doi=10.1016/j.jval.2015.09.526
First page :
A867
Section Title :
Research Podium Presentations - Session 1
Open access? :
No
Section Order :
2745